Orciprenaline (CAS 586-06-1) Suppliers and Product Information

Orciprenaline, also known as metaproterenol, is a bronchodilator used in the treatment of asthma. It is a moderately selective β2 adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle. It is available in various forms, including inhalation (MDI) and tablets.

Orciprenaline has a bioavailability of 3% if inhaled and 40% if taken orally. It is metabolized in the gastrointestinal tract and liver, with an elimination half-life of 6 hours.

Frequently Asked Questions about Orciprenaline

Q: What is the main use of Orciprenaline?

A: Orciprenaline is primarily used as a bronchodilator in the treatment of asthma.

Q: What are some possible side effects of Orciprenaline?

A: Common side effects may include tremor, nervousness, dizziness, weakness, headache, nausea, and tachycardia. Rare but potentially life-threatening side effects can include increased difficulty breathing, rapid or irregular heartbeat, and chest pain or discomfort.

Q: What are some brand names for Orciprenaline?

A: Some brand names for Orciprenaline include Alupent, Metaprel, and Orcibest.

Q: How does Orciprenaline work?

A: Orciprenaline works by stimulating β2 adrenergic receptors, which leads to the relaxation of bronchial smooth muscle and inhibition of the release of mediators from mast cells.